Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Vivosim Lab Inc (VIVS)

Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer GlobeNewswire - Thu Aug 14, 7:05AM CDT

SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing...

VIVS : 2.35 (-0.42%)
VivoSim: Fiscal Q1 Earnings Snapshot AP - Tue Aug 12, 3:44PM CDT

VivoSim: Fiscal Q1 Earnings Snapshot

VIVS : 2.35 (-0.42%)
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference GlobeNewswire - Tue May 13, 7:05AM CDT

VIVS : 2.35 (-0.42%)
VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference GlobeNewswire - Wed May 7, 7:05AM CDT

VIVS : 2.35 (-0.42%)
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market GlobeNewswire - Thu Apr 24, 7:05AM CDT

VIVS : 2.35 (-0.42%)
ONVO : 2.04 (+1.49%)

Barchart Exclusives

Nearly 45% of Its Float Is Being Sold Short. Should You Bet on iRobot Stock Here? Barchart - 1 hour ago
iRobot stock pushes further up as meme enthusiasts continue to flock into the consumer robots specialist. Here’s why investors are recommended against chasing the rally in IRBT shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot